Weigang Tong

1.7k total citations
30 papers, 1.4k citations indexed

About

Weigang Tong is a scholar working on Molecular Biology, Pharmacology and Hematology. According to data from OpenAlex, Weigang Tong has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pharmacology and 9 papers in Hematology. Recurrent topics in Weigang Tong's work include Inflammatory mediators and NSAID effects (9 papers), Acute Myeloid Leukemia Research (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Weigang Tong is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Acute Myeloid Leukemia Research (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Weigang Tong collaborates with scholars based in United States and Germany. Weigang Tong's co-authors include Thomas E. Adrian, Xianzhong Ding, Xianzhong Ding, Richard C. Witt, René Hennig, Jens Standop, Parviz M. Pour, Marina Talamonti, Richard H. Bell and Leanne M. Wiedemann and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Weigang Tong

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weigang Tong United States 18 632 451 270 198 194 30 1.4k
Yasunori Tsubouchi Japan 17 853 1.3× 609 1.4× 201 0.7× 446 2.3× 244 1.3× 32 1.7k
Adel Kardosh United States 19 424 0.7× 284 0.6× 419 1.6× 135 0.7× 109 0.6× 75 1.4k
Angela M. Acquaviva Italy 19 427 0.7× 294 0.7× 220 0.8× 145 0.7× 177 0.9× 33 1.1k
Joanne R. Brown United Kingdom 11 459 0.7× 463 1.0× 339 1.3× 234 1.2× 215 1.1× 13 1.3k
Mustapha Kandouz United States 25 979 1.5× 211 0.5× 305 1.1× 279 1.4× 249 1.3× 42 1.6k
Daisuke Kamei Japan 20 720 1.1× 829 1.8× 221 0.8× 252 1.3× 402 2.1× 33 1.7k
ShouWei Han United States 20 1.1k 1.7× 229 0.5× 266 1.0× 412 2.1× 116 0.6× 30 1.6k
Hiroshi Kuwata Japan 20 1.1k 1.8× 313 0.7× 177 0.7× 387 2.0× 198 1.0× 43 1.9k
Sung Hyeok Hong United States 10 324 0.5× 218 0.5× 272 1.0× 174 0.9× 131 0.7× 17 860
Russell D. Klein United States 20 524 0.8× 305 0.7× 229 0.8× 246 1.2× 290 1.5× 24 1.1k

Countries citing papers authored by Weigang Tong

Since Specialization
Citations

This map shows the geographic impact of Weigang Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Tong more than expected).

Fields of papers citing papers by Weigang Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weigang Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Tong. The network helps show where Weigang Tong may publish in the future.

Co-authorship network of co-authors of Weigang Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Weigang Tong. A scholar is included among the top collaborators of Weigang Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang Tong. Weigang Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bar, Merav, Weigang Tong, Megan Othus, Keith R. Loeb, & Elihu H. Estey. (2014). Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(3). 546–551. 27 indexed citations
2.
Bar, Merav, Weigang Tong, Megan Othus, Keith R. Loeb, & Elihu H. Estey. (2014). Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation. Blood. 124(21). 3941–3941.
3.
Tong, Weigang, Alfonso Quintás‐Cardama, Tapan M. Kadia, et al.. (2012). Predicting survival of patients with hypocellular myelodysplastic syndrome. Cancer. 118(18). 4462–4470. 29 indexed citations
4.
Wei, Yue, Tapan M. Kadia, Weigang Tong, et al.. (2010). The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy. Clinical Cancer Research. 16(15). 3923–3932. 58 indexed citations
5.
Tong, Weigang, Hagop M. Kantarjian, Susan O’Brien, et al.. (2010). Imatinib front‐line therapy is safe and effective in patients with chronic myelogenous leukemia with pre‐existing liver and/or renal dysfunction. Cancer. 116(13). 3152–3159. 22 indexed citations
6.
7.
Kuang, Shao-Qing, Hao Bai, Gonzalo López, et al.. (2010). Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia. Blood. 115(12). 2412–2419. 81 indexed citations
8.
Zweidler‐McKay, Patrick A., et al.. (2008). Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.. Blood. 112(11). 3372–3372.
9.
10.
Quintás‐Cardama, Alfonso, Taghi Manshouri, Weigang Tong, et al.. (2007). The dual ABL/SRC inhibitors dasatinib, SKI-606, and INNO-406 are potent inhibitors of T cell acute lymphoblastic leukemia cell lines expressing the NUP214-ABL1 fusion kinase. Cancer Research. 67. 1825–1825. 1 indexed citations
11.
Tong, Weigang, Xianzhong Ding, Marina Talamonti, Richard H. Bell, & Thomas E. Adrian. (2007). Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anti-Cancer Drugs. 18(5). 535–541. 26 indexed citations
12.
13.
Zhang, Jiwang, Xi He, Weigang Tong, et al.. (2006). Bone Morphogenetic Protein Signaling Inhibits Hair Follicle Anagen Induction by Restricting Epithelial Stem/Progenitor Cell Activation and Expansion. Stem Cells. 24(12). 2826–2839. 141 indexed citations
14.
Tong, Weigang, Xianzhong Ding, Marina Talamonti, Richard H. Bell, & Thomas E. Adrian. (2005). LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochemical and Biophysical Research Communications. 335(3). 949–956. 98 indexed citations
15.
Hennig, René, Xianzhong Ding, Weigang Tong, et al.. (2004). Effect of LY293111 in combination with gemcitabine in colonic cancer. Cancer Letters. 210(1). 41–46. 30 indexed citations
16.
Ding, Xianzhong, Weigang Tong, & Thomas E. Adrian. (2003). Multiple Signal Pathways Are Involved in the Mitogenic Effect of 5(S)-HETE in Human Pancreatic Cancer. Oncology. 65(4). 285–294. 39 indexed citations
17.
Hennig, René, Xianzhong Ding, Weigang Tong, et al.. (2002). 5-Lipoxygenase and Leukotriene B4 Receptor Are Expressed in Human Pancreatic Cancers But Not in Pancreatic Ducts in Normal Tissue. American Journal Of Pathology. 161(2). 421–428. 155 indexed citations
18.
Ding, Xianzhong, Weigang Tong, & Thomas E. Adrian. (2001). 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferationvia protein tyrosine phosphorylation and ERK activation. International Journal of Cancer. 94(5). 630–636. 74 indexed citations
19.
Ding, Xianzhong, Weigang Tong, & Thomas E. Adrian. (2001). Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology. 1(4). 291–299. 73 indexed citations
20.
Ding, Xianzhong, Weigang Tong, & Thomas E. Adrian. (2000). Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.. PubMed. 20(4). 2625–31. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasunori Tsubouchi Breakdown of academic impact, for papers by Adel Kardosh Breakdown of academic impact, for papers by Angela M. Acquaviva Breakdown of academic impact, for papers by Joanne R. Brown Breakdown of academic impact, for papers by Mustapha Kandouz Breakdown of academic impact, for papers by Daisuke Kamei Breakdown of academic impact, for papers by ShouWei Han Breakdown of academic impact, for papers by Hiroshi Kuwata Breakdown of academic impact, for papers by Sung Hyeok Hong Breakdown of academic impact, for papers by Russell D. Klein
Rankless by CCL
2026